Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Incidence of adverse events (AEs) during 12 weeks of treatment
| Evogliptin (n = 101) | Linagliptin (n = 105) | |
|---|---|---|
| AEs | 30 (29.7%) | 42 (40.0%) |
| Infections | 4 (4.0%) | 10 (9.5%) |
| Gastrointestinal disorders | 4 (4.0%) | 3 (2.9%) |
| Renal and urinary disorders | 0 (0.0%) | 4 (3.8%) |
| Hypoglycaemia | 13 (12.9%) | 14 (13.3%) |
| Adverse drug reactions | 4 (4.0%) | 5 (4.8%) |
| Serious adverse events | 2 (2.0%) | 3 (2.9%) |
| Documented symptomatic hypoglycaemia | 0 (0.0%) | 1 (1.0%) |
| Asymptomatic hypoglycaemia | 13 (12.9%) | 14 (13.3%) |
